Russell Investments Group, Ltd. Aurinia Pharmaceuticals Inc. Transaction History
Russell Investments Group, Ltd.
- $75.4 Billion
- Q2 2025
A detailed history of Russell Investments Group, Ltd. transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 82,509 shares of AUPH stock, worth $976,906. This represents 0.0% of its overall portfolio holdings.
Number of Shares
82,509
Previous 77,843
5.99%
Holding current value
$976,906
Previous $625,000
11.68%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding AUPH
# of Institutions
245Shares Held
62.5MCall Options Held
1.03MPut Options Held
666K-
Tang Capital Management LLC San Diego, CA10MShares$119 Million5.09% of portfolio
-
Black Rock Inc. New York, NY9.27MShares$110 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$47 Million2.79% of portfolio
-
State Street Corp Boston, MA2.8MShares$33.1 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.4MShares$28.4 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.68B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...